---
title: "Chimeric Therapeutics Issues New Shares to Boost Funding"
date: "2025-02-12 07:18:40"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioChimeric Therapeutics Ltd. ( (AU:CHM) )..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1279492897-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

Chimeric Therapeutics Ltd. ( [(AU:CHM)](https://www.tipranks.com/stocks/au:chm) ) has issued an announcement.

Chimeric Therapeutics has announced the issuance of up to 124,888,889 new fully paid ordinary shares to Lind Global Fund II, LP, as part of a share subscription agreement. This move aims to facilitate funding previously advanced by Lind, potentially enhancing the company’s financial stability and market operations.

**More about Chimeric Therapeutics Ltd.**

Chimeric Therapeutics Limited is an Australian company specializing in cell therapy, positioning itself as a leader in the biotechnology sector. The company focuses on developing innovative treatments and therapies, with a market emphasis on advanced cell-based solutions.

**Average Trading Volume:** 2,633,915

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** A$11.03M

For detailed information about CHM stock, go to [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/au:chm/stock-analysis).

Trending Articles:
------------------

* [M&A News: Paramount (NASDAQ:PARA) Merger Wins EU Approval](https://www.tipranks.com/news/ma-news-paramount-nasdaqpara-merger-wins-eu-approval)
* [Ford (NYSE:F) F-250 Super Duty Takes a Big Win in Value](https://www.tipranks.com/news/ford-nysef-f-250-super-duty-takes-a-big-win-in-value)
* [Intel (NASDAQ:INTC) Gets a Powerful Friend In JD Vance](https://www.tipranks.com/news/intel-nasdaqintc-gets-a-powerful-friend-in-jd-vance)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-issues-new-shares-to-boost-funding)
